By Market News Video Staff, Friday, November 19, 12:30 PM ET
Jefferies (JEF) cut its price target on Humana (NYSE:HUM) share from $65 to $61 per share, and maintained its hold rating.
Jefferies also cut its earnings and revenue guidance for the company, after Humana said it expects 2011 earnings of $5.35 to $5.55 yesterday, below Jefferies’ prior forecast for the company. Humana shares are trading lower again today, off 1% at the moment.
At 4.97% of the portfolio, the stock is the fourth-largest holding in the Dynamic Healthcare Portfolio (PTJ), which is trading about flat so far. Medco Health Solutions (MHS) is the top holding in the fund at 5.66% of the portfolio, followed by Express Scripts (NASDAQ:ESRX) is 5.09% of the portfolio, Cardinal Health (NYSE:CAH) at 5.06% and Quest Diagnostics (NYSE:DGX) at 4.87% of the fund.
The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors — anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.
This Article's Word Cloud:CardinalDynamicESRXExpressHealthHealthcareHumanaInvestmentJefferiesNYSEPortfolioQuestSolutionsaboutallowsalsoassetbelowbondsclassescompanycompletecompletelycountriesdesignedearningsflatfollowfollowedfourthfundgrowthguidanceholdinginvestorslargestleadsmaintainedperformanceportfoliopriceprogramratingsharesharesshortstockstermstradingyesterday
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.